The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Co-Amoxiclav Sugar Free 400 mg/57 mg/5 ml Powder for Oral Suspension

400/57 mg/5ml Powder for oral suspension

Brown & Burk IR LimitedPA23148/005/002

Main Information

Trade NameCo-Amoxiclav Sugar Free 400 mg/57 mg/5 ml Powder for Oral Suspension
Active SubstancesAmoxicillin
Clavulanic acid
Strength400/57 mg/5ml
Dosage FormPowder for oral suspension
Licence HolderBrown & Burk IR Limited
Licence NumberPA23148/005/002

Group Information

ATC CodeJ01CR Combinations of penicillins, incl. beta-lactamase inhibitors
J01CR02 amoxicillin and enzyme inhibitor


Licence Issued09/11/2012
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0037-076-034
Interchangeable List DocumentPDF of Interchangeable List
« Back